info@scandiedge.com
Toggle menu
About Us
Our Science
The Team
Pipeline
Phase I: METABOLIC COFACTORS
Phase II: NAFLD
Phase II: AD/PD
Publications
News
Contact
Board Member
ScandiEdge Therapeutics
→
Board Member
CEO
Dr Marianne Hansson
Chairman
Professor Mathias Uhlen
Board Member
Professor Adil Mardinoglu
Board Member
Professor Jan Boren